U.S. Pharmaceutical Supply Chain Gets a Boost from APIIC Initiative

URLhttps://www.contractpharma.com/contents/view_break
SourceContract Pharma
Date Published09/16/2024

Additional Reshoring Information:

Company/Division name API Innovation Center
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2024
Domestically, the work will be done:In-house
Capital investment ($):16.4
City reshored to:St. Louis
State(s) reshored to:MO
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredactive pharmaceutical ingredients (APIs)
What non-domestic negative factors made offshoring less attractive?Supply chain interruption
What domestic positive factors made reshoring more attractive?Government Incentives
Government Incentive dollar amount:$14 million
Find Reshoring Articles